← Back to all trials
Active Not Recruiting
NCT05937308
NEUROMARK Registry Study
Conditions: Chronic Rhinitis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 150
Sponsor: Neurent Medical
Location: Alabama Nasal & Sinus Center Birmingham Alabama
Summary
The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.
Eligibility Criteria
Inclusion Criteria:
Subject MUST:
1. Be ≥18 years of age.
2. Be scheduled to receive treatment with the commercially available NEUROMARK System consistent with the device's indications for use.
3. Have moderate to severe symptoms of running nose (individual rTNSS symptom rating of 2 or 3), mild to severe symptoms of nasal congestion (individual rTNSS symptom rating of 1, 2, or 3), and a minimum total score of 5 (out of 12) at screening.
4. Be willing and able to provide consent and comply with all study elements, as indicated by written informed consent.
Exclusion Criteria:
Subjects Must Not:
1\. Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.
Source: ClinicalTrials.gov (NCT05937308). StuddyBuddy aggregates publicly available trial information.
